A detailed history of Highlander Capital Management, LLC transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Highlander Capital Management, LLC holds 72,100 shares of TEVA stock, worth $1.19 Million. This represents 0.42% of its overall portfolio holdings.

Number of Shares
72,100
Previous 62,850 14.72%
Holding current value
$1.19 Million
Previous $656,000 55.03%
% of portfolio
0.42%
Previous 0.28%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 20, 2024

BUY
$10.67 - $14.43 $98,697 - $133,477
9,250 Added 14.72%
72,100 $1.02 Million
Q4 2023

Jan 24, 2024

SELL
$8.12 - $10.63 $4,059 - $5,315
-500 Reduced 0.79%
62,850 $656,000
Q3 2023

Nov 13, 2023

BUY
$7.48 - $10.7 $67,320 - $96,300
9,000 Added 16.56%
63,350 $646,000
Q2 2023

Aug 14, 2023

SELL
$7.2 - $9.47 $2,160 - $2,841
-300 Reduced 0.55%
54,350 $409,000
Q4 2022

Feb 15, 2023

SELL
$7.95 - $9.48 $16,695 - $19,908
-2,100 Reduced 3.7%
54,650 $498,000
Q3 2022

Nov 14, 2022

BUY
$6.86 - $11.95 $19,208 - $33,460
2,800 Added 5.19%
56,750 $458,000
Q2 2022

Aug 15, 2022

SELL
$7.38 - $10.4 $3,985 - $5,616
-540 Reduced 0.99%
53,950 $406,000
Q1 2022

May 09, 2022

SELL
$7.33 - $9.39 $7,330 - $9,390
-1,000 Reduced 1.8%
54,490 $512,000
Q4 2021

Feb 14, 2022

SELL
$7.9 - $10.19 $1,580 - $2,038
-200 Reduced 0.36%
55,490 $444,000
Q3 2021

Nov 15, 2021

SELL
$8.38 - $10.18 $7,542 - $9,162
-900 Reduced 1.59%
55,690 $542,000
Q1 2021

May 14, 2021

BUY
$10.34 - $12.81 $349,492 - $432,978
33,800 Added 148.31%
56,590 $653,000
Q4 2020

Feb 12, 2021

SELL
$8.61 - $11.04 $10,762 - $13,799
-1,250 Reduced 5.2%
22,790 $220,000
Q3 2020

Nov 17, 2020

SELL
$8.57 - $12.69 $12,855 - $19,035
-1,500 Reduced 5.87%
24,040 $217,000
Q1 2020

May 27, 2020

SELL
$6.69 - $13.45 $8,362 - $16,812
-1,250 Reduced 4.67%
25,540 $229,000
Q4 2019

Feb 13, 2020

SELL
$6.53 - $10.72 $53,546 - $87,904
-8,200 Reduced 23.44%
26,790 $263,000
Q3 2019

Nov 14, 2019

SELL
$6.16 - $9.6 $27,720 - $43,200
-4,500 Reduced 11.4%
34,990 $241,000
Q2 2019

Aug 14, 2019

BUY
$8.12 - $15.72 $24,765 - $47,946
3,050 Added 8.37%
39,490 $364,000
Q1 2019

May 15, 2019

SELL
$15.58 - $20.01 $50,635 - $65,032
-3,250 Reduced 8.19%
36,440 $571,000
Q4 2018

Feb 14, 2019

SELL
$14.59 - $23.84 $26,262 - $42,912
-1,800 Reduced 4.34%
39,690 $618,000
Q3 2018

Nov 09, 2018

SELL
$21.06 - $25.65 $492,803 - $600,210
-23,400 Reduced 36.06%
41,490 $894,000
Q2 2018

Aug 15, 2018

BUY
$16.77 - $24.71 $16,770 - $24,710
1,000 Added 1.57%
64,890 $1.58 Million
Q1 2018

May 16, 2018

SELL
$16.68 - $22.07 $68,388 - $90,487
-4,100 Reduced 6.03%
63,890 $1.08 Million
Q4 2017

Feb 13, 2018

SELL
$11.23 - $19.1 $128,628 - $218,771
-11,454 Reduced 14.42%
67,990 $1.29 Million
Q3 2017

Nov 15, 2017

BUY
$15.41 - $32.17 $1.22 Million - $2.56 Million
79,444
79,444 $1.4 Million

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $18.4B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Highlander Capital Management, LLC Portfolio

Follow Highlander Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Highlander Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Highlander Capital Management, LLC with notifications on news.